Search

Anaphylaxis is an acute-onset, life-threatening, systemic hypersensitivity reaction. The acute reaction occurs due to a permanently immunologically altered response, which can result in mild to severe reactions and, in isolated cases, to fatal reactions upon allergen contact. The avoidance strategies required lifelong in affected individuals significantly impair quality of life. An expert analysis of the supportive care situation of anaphylaxis patients. The trigger of the reaction — mostly food, insect venom, or drugs — can normally be identified by means of allergy diagnostics. However, allergy workups unfortunately are not always performed in anaphylaxis patients. Unequivocal diagnosis and/or causal classification of the trigger is not always easy, particularly in the presence of summation factors, such as physical exertion or the use of analgesics or alcohol. Complex cases present too rarely in allergy centers with appropriate experience. Following anaphylaxis patients are given guidance on allergen avoidance and after obligatory instruction from a medical expert, receive a prescription for an emergency self-medication kit. However, studies show that allergen avoidance often fails and patient self-medication is frequently not performed. Therefore, the German working group on anaphylaxis training and education (Arbeitsgemeinschaft Anaphylaxie Training und Education, AGATE) formulated a structured written interdisciplinary educational training program that is currently used in 24 registered centers in Germany. In a multicenter study using control groups, the anaphylaxis training program showed significant efficacy in terms of practical emergency management and reduced anxiety. The nationwide implementation of the training program and cost-coverage by statutory health insurances appear reasonable given the potentially life-threatening nature of this disease. Since statutory health insurances have not guaranteed cost-coverage to date, it is not possible to offer the training program to all patients in need. Subject to region and center, there are good treatment options for anaphylaxis patients in Germany. However, these options are not always sufficiently implemented.

About 17% of German children and adolescents suffer from at least one of the following atopic illnesses: allergic rhinoconjunctivitis, atopic eczema or asthma. Consistent professional therapy is necessary to limit the health-related risks and improve these medical conditions. The consequences of a diagnosis often mean an additional task for the parents of diseased children, where they have to act simultaneously as an educator and therapist for their children. Structured educational programmes were developed for a few diseases such as asthma and atopic eczema in order to prepare parents and affected children to accept this important responsibility. Moreover, a structured programme for anaphylaxis is being developed. These proposals aim not only to transfer knowledge about the disease but also to effectively support self-reliant treatment and emotional coping with the disease as well as its collateral strain.

Background Structured educational programmes for patients at risk for anaphylaxis have not yet been established. Patients and caregivers often lack adequate skills in managing the disease. Methods To investigate effects of structured patient education intervention on knowledge, emergency management skills and psychological parameters in patients with previous episodes of anaphylaxis and caregivers of affected children 95 caregivers (11 male, 84 female, mean age 37 years) of affected children and 98 patients (32 male, 66 female, mean age 47.5 years) were randomly assigned to an intervention (IG) or control group (CG) in a multicentre randomized controlled trial. The IG received two 3-h schooling modules of group education; the CG received standard auto-injector training only. Knowledge of anaphylaxis and emergency management competence in a validated training anaphylaxis situation as main outcome measures as well as secondary psychological parameters were assessed at baseline and 3 months after intervention. Results In comparison with controls, the intervention led to significant improvement of knowledge from baseline to 3-month follow-up (caregivers: IG 3.2/13.2 improvement/baseline vs CG 0.7/12.6; P

About 17% of German children and adolescents suffer from at least one of the following atopic illnesses: allergic rhinoconjunctivitis, atopic eczema or asthma. Consistent professional therapy is necessary to limit the health-related risks and improve these medical conditions. The consequences of a diagnosis often mean an additional task for the parents of diseased children, where they have to act simultaneously as an educator and therapist for their children. Structured educational programmes were developed for a few diseases such as asthma and atopic eczema in order to prepare parents and affected children to accept this important responsibility. Moreover, a structured programme for anaphylaxis is being developed. These proposals aim not only to transfer knowledge about the disease but also to effectively support self-reliant treatment and emotional coping with the disease as well as its collateral strain.

BACKGROUND: Oral wheat plus cofactors challenge tests in patients with wheat-dependent exercise-induced anaphylaxis (WDEIA) produce unreliable results. OBJECTIVE: We sought to confirm WDEIA diagnosis by using oral gluten flour plus cofactors challenge, to determine the amount of gluten required to elicit symptoms, and to correlate these results with plasma gliadin levels, gastrointestinal permeability, and allergologic parameters. METHODS: Sixteen of 34 patients with a history of WDEIA and ω5-gliadin IgE underwent prospective oral challenge tests with gluten with or without cofactors until objective symptoms developed. Gluten reaction threshold levels, plasma gliadin concentrations, gastrointestinal permeability, sensitivities and specificities for skin prick tests, and specific IgE levels were ascertained in patients and 38 control subjects. RESULTS: In 16 of 16 patients (8 female and 8 male patients; age, 23-76 years), WDEIA was confirmed by challenges with gluten alone (n = 4) or gluten plus cofactors (n = 12), including 4 patients with previous negative wheat challenge results. Higher gluten doses or acetylsalicylic acid (ASA) plus alcohol instead of physical exercise were cofactors in 2 retested patients. The cofactors ASA plus alcohol and exercise increased plasma gliadin levels (P < .03). Positive challenge results developed after a variable period of time at peak or when the plateau plasma gliadin level was attained. Positive plasma gliadin threshold levels differed by greater than 100-fold and ranged from 15 to 2111 pg/mL (median, 628 pg/mL). The clinical history, IgE gliadin level, and baseline gastrointestinal level were not predictive of the outcomes of the challenge tests. The challenge-confirmed sensitivity and specificity of gluten skin prick tests was 100% and 96%, respectively. CONCLUSION: Oral challenge with gluten alone or along with ASA and alcohol is a sensitive and specific test for the diagnosis of WDEIA. Exercise is not an essential trigger for the onset of symptoms in patients with WDEIA.